Source link : https://newshealth.biz/health-news/combo-therapy-boosts-early-cml-response-but-not-long-term/
A phase 3 trial evaluates the efficacy and safety of nilotinib with pegylated interferon alfa-2a in patients with newly diagnosed chronic-phase chronic myeloid leukemia. Medscape Medical News Source link : https://www.medscape.com/viewarticle/combo-therapy-boosts-early-cml-response-not-long-term-2026a1000f6z?src=rss Author : Publish date : 2026-05-12 03:14:00 Copyright for syndicated content belongs to the linked Source.
The post Combo Therapy Boosts Early CML Response but Not Long Term first appeared on News Health.
—-
Author : News Health
Publish date : 2026-05-12 03:14:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8